Matthew Triplette, MD, MPH
Associate Professor
Public Health Sciences Division, Fred Hutch
Associate Professor
Clinical Research Division, Fred Hutch
Medical Director
Lung Cancer Screening, Fred Hutch
Medical Director
Living Tobacco Free Services, Fred Hutch
Dr. Matthew Triplette is a pulmonologist who studies how best to implement lung cancer screening to save the most lives. He explores the barriers and facilitators to screening as well as potential disparities. Dr. Triplette also studies lung disease and lung cancer in underserved and at-risk populations, including immunosuppressed patients with HIV or prior organ transplant.
Other Appointments & Affiliations
Associate Professor, Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington School of MedicineAssociate Professor, Division of Pulmonary, Critical Care and Sleep Medicine
University of Washington School of Medicine
Attending Physician
Fred Hutchinson Cancer Center
Education
Fellowship, Pulmonary and Critical Care Medicine, University of Washington, 2014-2017
Graduate studies, Epidemiology, University of Washington, 2015-2016
Residency, Internal Medicine, University of California, San Francisco, 2012-2014
Internship, Internal Medicine, University of California, San Francisco, 2011-2012
MD, University of North Carolina, Chapel Hill, 2011
MPH, Health Care and Prevention, University of North Carolina, Chapel Hill, 2010
Current Projects
COALS: Community-based Outcomes and Adherence for Lung cancer Screening
PEARLS: Patient Experiences with Adherence and navigation Resources in Lung cancer Screening
Research Focus
Dr. Triplette has studied racial disparities in coronary artery disease, chronic lung disease in HIV patients, and community-based screening for HIV and lung cancer. His current collaborative studies focus on lung cancer screening practices in underserved and at-risk populations. He is leading Fred Hutchinson Cancer Center and University of Washington efforts to examine the current implementation of lung cancer screening and better understand barriers, facilitators and potential disparities in screening practices. He is part of an ongoing clinical study of biomarkers of lung-related disease and has an ongoing interest in lung cancer in special at-risk populations, including immunosuppressed patients with HIV or prior organ transplant.